Download
s41375-020-0898-6.pdf 246,19KB
WeightNameValue
1000 Titel
  • Holding CoVID in check through JAK? The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic hyperinflammation
1000 Autor/in
  1. Heidel, F. |
  2. Hochhaus, A. |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-06-11
1000 Erschienen in
1000 Quellenangabe
  • 34(7):1723-1725
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1038/s41375-020-0898-6 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288260/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • The bone marrow is home to well-balanced normal hematopoiesis, but also the stage of leukemia's crime. Marrow adipose tissue (MAT) is a unique and versatile component of the bone marrow niche. While the importance of MAT for bone health has long been recognized, its complex role in hematopoiesis has only recently gained attention. In this review article we summarize recent conceptual advances in the field of MAT research and how these developments impact our understanding of MAT regulation of hematopoiesis. Elucidating routes of interaction and regulation between MAT and cells of the hematopoietic system are essential to pinpoint vulnerable processes resulting in malignant transformation. The concept of white adipose tissue contributing to cancer development and progression on the cellular, metabolic, and systemic level is generally accepted. The role of MAT in malignant hematopoiesis, however, is controversial. MAT is very sensitive to changes in the patient's metabolic status hampering a clear definition of its role in different clinical situations. Here, we discuss future directions for leukemia research in the context of metabolism-induced modifications of MAT and other adipose tissues and how this might impact on leukemia cell survival, proliferation, and antileukemic therapy.
1000 Sacherschließung
gnd 1206347392 COVID-19
lokal Pneumonia, Viral [MeSH]
lokal Coronavirus Infections [MeSH]
lokal Humans [MeSH]
lokal Infectious diseases
lokal Editorial
lokal Pandemics [MeSH]
lokal Pyrazoles [MeSH]
lokal COVID-19 [MeSH]
lokal Molecularly targeted therapy
lokal Betacoronavirus [MeSH]
lokal Janus Kinase 1 [MeSH]
lokal SARS-CoV-2 [MeSH]
lokal SARS Virus [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/SGVpZGVsLCBGLg==|https://frl.publisso.de/adhoc/uri/SG9jaGhhdXMsIEEu
1000 Hinweis
  • DeepGreen-ID: 326dde37da284434b3f78ced7d174e3c ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6471058.rdf
1000 Erstellt am 2023-11-18T10:37:44.360+0100
1000 Erstellt von 322
1000 beschreibt frl:6471058
1000 Zuletzt bearbeitet 2023-12-01T13:35:44.527+0100
1000 Objekt bearb. Fri Dec 01 13:35:44 CET 2023
1000 Vgl. frl:6471058
1000 Oai Id
  1. oai:frl.publisso.de:frl:6471058 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source